Ranbaxy CEO Plans Three Cancer Biosimilars In India Starting Next Year
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories plans to market at least three biosimilars at home by 2015 to continue being a key player in the global generics industry,